These results suggest that clenbuterol treatment rapidly suppresses TNFα expression after stroke and prolonged clenbuterol treatment after stroke onset subsequently results in a suppression of both pro- and anti-inflammatory responses. This evidence concerns the gene TNF and Stroke.